DiaMedica Therapeutics Inc

General ticker "DMAC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $226.3M

DiaMedica Therapeutics Inc follows the US Stock Market performance with the rate: 45.5%.

Estimated limits based on current volatility of 7.2%: low 5.02$, high 5.79$

Factors to consider:

  • Earnings for 6 months up through Q2 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.24$, 5.13$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.25$, 5.11$]

Financial Metrics affecting the DMAC estimates:

  • Negative: Non-GAAP EPS, $ of -0.62 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -17.44 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: -0.96 < Investing cash flow per share, $ of -0.56

Similar symbols

Short-term DMAC quotes

Long-term DMAC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $13.65MM $14.00MM $21.27MM
Operating Income $-13.65MM $-14.00MM $-21.27MM
Non-Operating Income $0.08MM $0.35MM $1.93MM
R&D Expense $8.77MM $7.84MM $13.11MM
Income(Loss) $-13.56MM $-13.65MM $-19.34MM
Taxes $0.03MM $0.03MM $0.04MM
Profit(Loss) $-13.59MM $-13.68MM $-19.38MM
Stockholders Equity $44.02MM $31.83MM $51.06MM
Inventory $0.11MM $0.00MM $0.00MM
Assets $45.55MM $34.40MM $54.16MM
Operating Cash Flow $-12.25MM $-11.51MM $-18.73MM
Capital expenditure $0.02MM $0.08MM $0.02MM
Investing Cash Flow $-20.54MM $11.54MM $-18.30MM
Financing Cash Flow $30.09MM $-0.01MM $36.84MM
Earnings Per Share* $-0.65 $-0.52 $-0.60

* EPS are Split Adjusted, recent splits may be reflected with a delay.